FindTrial
Sign In

Effects of atorvastatin calcium on cognitive function in patients with chronic subdural hematoma, a prospective, exploratory study

Effects of atorvastatin calcium on cognitive function in patients with chronic subdural hematoma, a prospective, exploratory study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063514
Enrollment
Unknown
Registered
2022-09-09
Start date
2022-08-27
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic subdural hematoma

Interventions

Case series:None

Sponsors

Tianjin Medical University General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age: 18-75 years old; 2. Gender: Both men and women; 3. Diseases: Patients diagnosed with chronic subdural hematoma based on CT or MRI imaging combined with clinical symptoms and signs.

Exclusion criteria

Exclusion criteria: 1. Acute/subacute subdural hematoma; 2. The patient has a history of dementia/cognitive dysfunction.

Design outcomes

Primary

MeasureTime frame
MoCA scores;—

Secondary

MeasureTime frame
Tau protein;—

Countries

China

Contacts

Public ContactJiang Rongcai

Tianjin Medical University General Hospital

jiang116216@163.com+86 13672116556

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026